Merck's Next Phase of Patient Centricity in R&D

PharmaTalkRadio

English - November 04, 2019 13:00 - 23 minutes - 20.5 MB - ★★★★ - 16 ratings
Science pharmaceutical biotech clinical trials patient engagement immuno-oncology drug delivery r&d Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Clinical update on AMG 420, an anti-BCMA BiTE®

Next Episode: Best Practices for Pharma - Patient Advocacy Partnerships

In this podcast, hear a session from the 2019 Patients as Partners EU meeting where Merck's Vanessa Pott presented a case study on Innovative Medicines Development and Merck KGaA's next phase of Patient Centricity in R&D.

The 4th annual Patients as Partners EU conference will take place on January 27-28, 2020 in London, UK.

To learn more about the program and patient centricity in R&D, visit theconferenceforum.org.